This consistency may maintain therapeutic levels, supporting ongoing metabolic processes and weight management efforts
Sn phm ny khng phi l thuc khng c tc dng thay th thuc cha bnh
In addition, similar to other GLP-1 RAs, it affects different stages of the pathophysiological process of CVDs, from risk factors like dyslipidemia, hypertension, obesity, diabetes, and coronary artery atherosclerosis to more advanced stages such as myocardial ischemia, atherothrombosis, myocardial infarction, left ventricular remodeling, and death, without raising the risk of arrhythmia, hospitalization, or exacerbating heart failure [35, 41]
With semaglutide , common side effects include: Nausea Vomiting Diarrhea Constipation Abdominal pain Read more: Semaglutide side effects: Symptom guide & management tips With retatrutide , early clinical trials show a very similar pattern so far, including: Nausea (often the most reported) Diarrhea Constipation Vomiting Lets take a look at how some of those most common side effects compare between semaglutide (Wegovy 2.4 mg and 7.2 mg) and retatrutide
Given the explorative nature of the present study and the primary focus on C8-carnitine (with other acyl-carnitines as secondary endpoints), we did not apply multiple comparison corrections for the primary analysis